Niva Bupa Health Insurance Company Limited
Niva Bupa Health Insurance Company Limited (NIVABUPA) financial statements and selected valuation metrics from NSE/BSE exchange filings through 31 March 2026.
Financial Services›Financial Services›Insurance›General Insurance
nivabupa.com(opens the company website in a new tab)Key metrics
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Insurance layout · ₹ Cr · quarterly
| Metric | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
|---|---|---|---|---|
| Premium | 1,672 Cr | 1,288 Cr | 1,450 Cr | 1,767 Cr |
| Expenses | 313 Cr | 244 Cr | 308 Cr | 317 Cr |
| Operating profit | 1,359 Cr | 1,044 Cr | 1,142 Cr | 1,450 Cr |
| Investment income | — | — | — | — |
| Other income | -56 Cr | 2 Cr | 18 Cr | 7 Cr |
| Profit before tax | 206 Cr | -91 Cr | -35 Cr | -88 Cr |
| Tax % | 0.0% | 0.0% | 0.0% | 0.0% |
| Net profit | — | — | — | — |
| EPS (₹) | ₹1.13 | ₹-0.50 | ₹-0.19 | ₹-0.47 |
Profit & loss (annual)
Annual insurance P&L · TTM where available · ₹ Cr
| Metric | Mar 2025 | TTM |
|---|---|---|
| Premium | 5,369 Cr | Sign in for TTM |
| Expenses | 1,083 Cr | Sign in for TTM |
| Operating profit | 4,286 Cr | Sign in for TTM |
| Investment income | — | Sign in for TTM |
| Other income | 142 Cr | Sign in for TTM |
| Profit before tax | 214 Cr | Sign in for TTM |
| Tax % | 0.0% | Sign in for TTM |
| Net profit | — | Sign in for TTM |
| EPS (₹) | ₹1.22 | Sign in for TTM |
| Dividend payout % | — | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 |
|---|---|
| Equity capital | — |
| Reserves | 1,950 Cr |
| Borrowings | 250 Cr |
| Other liabilities | — |
| Total liabilities | 9,760 Cr |
| Fixed assets (net) | 75 Cr |
| CWIP | — |
| Investments | 8,175 Cr |
| Cash & bank | 220 Cr |
| Other assets | 1,289 Cr |
| Total assets | 9,760 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2025 |
|---|---|
| Cash from operating activity | 1,654 Cr |
| Cash from investing | -2,348 Cr |
| Cash from financing | 771 Cr |
| Net cash flow | 78 Cr |
| Free cash flow (OCF − Capex) | 1,613 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2025 |
|---|---|
| ROCE % | — |
| ROE % | — |
| Debtor days | — |
| Inventory days | — |
| Days payable | — |
| Cash conversion cycle | — |
| Debt / equity | — |
| Current ratio | 0.40 |
| Net debt / EBITDA | — |
Compare with peers
Loading peers…